New 52 Week Low Today

Vaccinex Inc VCNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 6:31 PM EDT
0.48UNCH (UNCH)
Volume
100
Close
0.4765quote price arrow down-0.0043 (-0.884%)
Volume
24,649
52 week range
0.45 - 2.37
Loading...
  • Open0.48
  • Day High0.4927
  • Day Low0.45
  • Prev Close0.4808
  • 52 Week High2.37
  • 52 Week High Date11/03/21
  • 52 Week Low0.45
  • 52 Week Low Date09/23/22

Key Stats

  • Market Cap20.33M
  • Shares Out42.66M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.21
  • YTD % Change-54.18

KEY STATS

  • Open0.48
  • Day High0.4927
  • Day Low0.45
  • Prev Close0.4808
  • 52 Week High2.37
  • 52 Week High Date11/03/21
  • 52 Week Low0.45
  • 52 Week Low Date09/23/22
  • Market Cap20.33M
  • Shares Out42.66M
  • 10 Day Average Volume0.12M
  • Dividend-
  • Dividend Yield-
  • Beta1.21
  • YTD % Change-54.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.56
  • P/E (TTM)-0.84
  • Fwd P/E (NTM)-0.42
  • EBITDA (TTM)-20.403M
  • ROE (TTM)-142.13%
  • Revenue (TTM)50,000.00
  • Gross Margin (TTM)0.00%
  • Net Margin (TTM)-39,630.00%
  • Debt To Equity (MRQ)1.94%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Vaccinex Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Vaccinex, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab (VX15/2503), is a humanized monoclonal antibody that binds and blocks the signaling activity of semaphorin 4D (SEMA4D). It is focused on the development of...
Address
1895 Mount Hope Ave
Rochester, NY
14620-4540
United States

Top Peers

SYMBOLLASTCHG%CHG
CANF
Can Fite Biopharma Ltd
0.7411-0.0189-2.4868%
SNGX
Soligenix Inc
0.4908+0.0032+0.66%
ACER
Acer Therapeutics Inc
1.45+0.10+7.41%
IKT
Inhibikase Therapeutics Inc
0.85+0.005+0.59%
ONTX
Onconova Therapeutics Inc
0.9001-0.0272-2.9332%
PYPD
PolyPid Ltd
1.09+0.02+1.87%